en

PRODUCT DETAIL

Emtricitabine/Rilpivirine/Tenofovir alafenamide Viatris 200 mg/25 mg/25 mg filmom obalené tablety

Code 0994F
MA number EU/1/25/1966/002
Product Form: tbl flm 90x200 mg/25 mg/25 mg (blis.OPA/Al/PE/vysúšadlo/HDPE-Al/PE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Viatris Limited, Ireland
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR19 Emtricitabine, tenofovir alafenamide and rilpivirine
Shelf life: 12
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 19.08.2025
Validity: 19.08.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 05.09.2025
eu-flag.png sk-flag.png